Wen et al. demonstrated upregulation of PD-L1 on CT26 and MC38 colon adenocarcinoma tumors following treatment with integrin αvβ3 targeted 177Lu, showing a cooperative effect between TRT agents and immune checkpoint blockade [57]. Here, CD274 is linked to colon adenocarcinoma.